Revolution Medicines, Inc. Increase (Decrease) in Other Noncurrent Liabilities
Revolution Medicines, Inc. (RVMD) reported Increase (Decrease) in Other Noncurrent Liabilities of $440.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-08-05
- Revolution Medicines, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was -$5.22M, a 326.64% decline year-over-year.
- Revolution Medicines, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was $5.66M, a 63.32% increase year-over-year.
- Revolution Medicines, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was -$1.27M.
- Revolution Medicines, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was -$3.97M, a 468.93% decline year-over-year.
- Revolution Medicines, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2025 was $537.00K, a 153.30% increase from fiscal 2024.
- Revolution Medicines, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2024 was $212.00K, a 35.03% increase from fiscal 2023.
- Revolution Medicines, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2023 was $157.00K.
- Revolution Medicines, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2022 was -$190.00K, a 225.83% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$5.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $440.00K 10-Q · filed 2026-08-05 | -$830.00K derived: sum of 3 quarters · filed 2026-08-05 | -$4.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $5.66M 10-Q · filed 2026-05-06 | $4.39M derived: sum of 2 quarters · filed 2026-05-06 | $428.00K derived: sum of 3 quarters · filed 2026-05-06 | $2.73M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$5.24M derived: sum of 2 quarters · filed 2026-02-25 | -$2.93M derived: sum of 3 quarters · filed 2026-08-05 | $537.00K 10-K · filed 2026-02-25 |
| 2025-09-30 | -$3.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.66M derived: sum of 2 quarters · filed 2026-08-05 | $1.81M 10-Q · filed 2025-11-05 | $1.04M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.77M 10-Q · filed 2026-08-05 | $5.00M derived: sum of 3 quarters · filed 2026-08-05 | $6.08M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $3.47M 10-Q · filed 2026-05-06 | $2.70M derived: sum of 2 quarters · filed 2026-05-06 | $3.77M derived: sum of 3 quarters · filed 2026-05-06 | $1.55M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$768.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $307.00K derived: sum of 2 quarters · filed 2026-02-25 | -$1.92M derived: sum of 3 quarters · filed 2026-02-25 | $212.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.15M derived: sum of 2 quarters · filed 2025-11-05 | $980.00K 10-Q · filed 2025-11-05 | $456.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$95.00K 10-Q · filed 2025-08-06 | -$619.00K derived: sum of 3 quarters · filed 2026-02-25 | $111.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $2.13M 10-Q · filed 2025-05-07 | $1.61M derived: sum of 2 quarters · filed 2026-02-25 | $2.34M derived: sum of 3 quarters · filed 2026-02-25 | $896.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$524.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $206.00K derived: sum of 2 quarters · filed 2026-02-25 | -$1.24M derived: sum of 3 quarters · filed 2026-02-25 | $157.00K 10-K · filed 2026-02-25 |
| 2023-09-30 | $730.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$712.00K derived: sum of 2 quarters · filed 2024-11-06 | $681.00K 10-Q · filed 2024-11-06 | $511.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | -$1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$49.00K 10-Q · filed 2024-08-07 | -$219.00K derived: sum of 3 quarters · filed 2025-02-26 | $121.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $1.39M 10-Q · filed 2024-05-08 | $1.22M derived: sum of 2 quarters · filed 2025-02-26 | $1.56M derived: sum of 3 quarters · filed 2025-02-26 | $172.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | -$170.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $170.00K derived: sum of 2 quarters · filed 2025-02-26 | -$1.22M derived: sum of 3 quarters · filed 2025-02-26 | -$190.00K 10-K · filed 2025-02-26 |
| 2022-09-30 | $340.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$1.05M derived: sum of 2 quarters · filed 2023-11-06 | -$20.00K 10-Q · filed 2023-11-06 | -$291.00K derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | -$1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$360.00K 10-Q · filed 2023-08-08 | -$631.00K derived: sum of 3 quarters · filed 2024-02-26 | -$265.00K derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $1.03M 10-Q · filed 2023-05-08 | $760.00K derived: sum of 2 quarters · filed 2024-02-26 | $1.13M derived: sum of 3 quarters · filed 2024-02-26 | $329.00K derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | -$271.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $95.00K derived: sum of 2 quarters · filed 2024-02-26 | -$702.00K derived: sum of 3 quarters · filed 2024-02-26 | $151.00K 10-K · filed 2024-02-26 |
| 2021-09-30 | $366.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$431.00K derived: sum of 2 quarters · filed 2022-11-07 | $422.00K 10-Q · filed 2022-11-07 | $32.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | -$797.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $56.00K 10-Q · filed 2022-08-09 | -$334.00K derived: sum of 3 quarters · filed 2023-02-27 | $105.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $853.00K 10-Q · filed 2022-05-09 | $463.00K derived: sum of 2 quarters · filed 2023-02-27 | $902.00K derived: sum of 3 quarters · filed 2023-02-27 | $1.05M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | -$390.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $49.00K derived: sum of 2 quarters · filed 2023-02-27 | $195.00K derived: sum of 3 quarters · filed 2023-02-27 | $176.00K 10-K · filed 2023-02-27 |
| 2020-09-30 | $439.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $585.00K derived: sum of 2 quarters · filed 2021-11-10 | $566.00K 10-Q · filed 2021-11-10 | $540.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $146.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $127.00K 10-Q · filed 2021-08-11 | $101.00K derived: sum of 3 quarters · filed 2022-02-28 | $95.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$19.00K 10-Q · filed 2021-05-10 | -$45.00K derived: sum of 2 quarters · filed 2022-02-28 | -$51.00K derived: sum of 3 quarters · filed 2022-02-28 | -$95.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$32.00K derived: sum of 2 quarters · filed 2022-02-28 | -$76.00K derived: sum of 3 quarters · filed 2022-02-28 | $184.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$50.00K derived: sum of 2 quarters · filed 2020-11-12 | $210.00K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | -$44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $216.00K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $260.00K 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | $311.00K 10-K · filed 2021-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |